Style | Citing Format |
---|---|
MLA | Nasiri S, et al.. "Investigating the Effectiveness of Intraoperative Rapid Parathyroid Hormone Assay in Parathyroidectomy Surgery in Patients With Secondary Hyperparathyroidism." BMC Endocrine Disorders, vol. 23, no. 1, 2023, pp. -. |
APA | Nasiri S, Meshkati Yazd SM, Heshmati A, Mokhtari Ardekani A, Najafi M, Shahriarirad R (2023). Investigating the Effectiveness of Intraoperative Rapid Parathyroid Hormone Assay in Parathyroidectomy Surgery in Patients With Secondary Hyperparathyroidism. BMC Endocrine Disorders, 23(1), -. |
Chicago | Nasiri S, Meshkati Yazd SM, Heshmati A, Mokhtari Ardekani A, Najafi M, Shahriarirad R. "Investigating the Effectiveness of Intraoperative Rapid Parathyroid Hormone Assay in Parathyroidectomy Surgery in Patients With Secondary Hyperparathyroidism." BMC Endocrine Disorders 23, no. 1 (2023): -. |
Harvard | Nasiri S et al. (2023) 'Investigating the Effectiveness of Intraoperative Rapid Parathyroid Hormone Assay in Parathyroidectomy Surgery in Patients With Secondary Hyperparathyroidism', BMC Endocrine Disorders, 23(1), pp. -. |
Vancouver | Nasiri S, Meshkati Yazd SM, Heshmati A, Mokhtari Ardekani A, Najafi M, Shahriarirad R. Investigating the Effectiveness of Intraoperative Rapid Parathyroid Hormone Assay in Parathyroidectomy Surgery in Patients With Secondary Hyperparathyroidism. BMC Endocrine Disorders. 2023;23(1):-. |
BibTex | @article{ author = {Nasiri S and Meshkati Yazd SM and Heshmati A and Mokhtari Ardekani A and Najafi M and Shahriarirad R}, title = {Investigating the Effectiveness of Intraoperative Rapid Parathyroid Hormone Assay in Parathyroidectomy Surgery in Patients With Secondary Hyperparathyroidism}, journal = {BMC Endocrine Disorders}, volume = {23}, number = {1}, pages = {-}, year = {2023} } |
RIS | TY - JOUR AU - Nasiri S AU - Meshkati Yazd SM AU - Heshmati A AU - Mokhtari Ardekani A AU - Najafi M AU - Shahriarirad R TI - Investigating the Effectiveness of Intraoperative Rapid Parathyroid Hormone Assay in Parathyroidectomy Surgery in Patients With Secondary Hyperparathyroidism JO - BMC Endocrine Disorders VL - 23 IS - 1 SP - EP - PY - 2023 ER - |